Clinical and pre-clinical biomarkers of Regorafenib (REG) efficacy in metastatic colorectal cancer (mCRC) in a phase II trial

Authors :: C. Saffery
Nicola Valeri
Khurum Khan
Y. Jamin
Naureen Starling
Mihaela Rata
Sheela Rao
David Cunningham
D. Watkins
Somaieh Hedayat
Chiara Braconi
Clare Peckitt
Ian Chau
Matteo Fassan
Jens C. Hahne
George Vlachogiannis
N. Fotiadis
Dearbhaile Catherine Collins
D-M. Koh
Nina Tunariu
Source :: Annals of Oncology. 28:v31-v32
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
chemistry.chemical_compound
chemistry
Colorectal cancer
business.industry
Internal medicine
Regorafenib
medicine
Hematology
medicine.disease
business

Full Text Access

Tools